ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
PharmaCyte Biotech Inc

PharmaCyte Biotech Inc (PMCB)

0.761
0.0109
(1.45%)
終了 6月15日 5:00AM
0.76
-0.001
(-0.13%)
取引時間後: 8:55AM

PharmaCyte Biotech Inc (PMCB) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.76
( 1.32% )
買値
0.754
売値
0.785
出来高
172,949
0.7566 日の範囲 0.805
0.63 52 週間の範囲 1.51
時価総額
前日終値
0.7501
始値
0.769
最終取引時間
財務取引量
US$ 134,318
VWAP
0.776633
平均取引量 (3 か月)
US$ 194,367
発行済株式数
10,735,649
配当利回り
PER
-0.69
1 株当たり利益 (EPS)
-1.01
歳入
-
純利益
-3.28M

PharmaCyte Biotech Inc について

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company’s cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based li... PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company’s cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Las Vegas, United States
設立
1996
PharmaCyte Biotech Inc is listed in the Healthcare sector of the ナスダック市場 with ticker PMCB. The last closing price for PharmaCyte Biotech was US$0.75. Over the last year, PharmaCyte Biotech shares have traded in a share price range of US$ 0.63 to US$ 1.51.

PharmaCyte Biotech currently has 10,735,649 shares in issue. The market capitalisation of PharmaCyte Biotech is US$8.16 million. PharmaCyte Biotech has a price to earnings ratio (PE ratio) of -0.69.

PMCB 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.045.555555555560.720.7798990.66721439220.7133046CS
4-0.18-19.14893617020.940.940.66721964730.77925951CS
120.05738.154262131780.70270.970.6300011992530.78939203CS
26-0.24-2411.050.632377090.81157222CS
52-0.3-28.30188679251.061.510.639442521.06665777CS
156-2.38-75.79617834393.143.180.633285881.10990812CS
260-2.32-75.32467532473.089.980.636345964.49086854CS

PMCB - Frequently Asked Questions (FAQ)

What is the current PharmaCyte Biotech Inc share price?
The current share price of PharmaCyte Biotech Inc is US$ 0.76
How many PharmaCyte Biotech Inc shares are in issue?
PharmaCyte Biotech Inc has 10,735,649 shares in issue
What is the market cap of PharmaCyte Biotech Inc?
The market capitalisation of PharmaCyte Biotech Inc is USD 8.16M
What is the 1 year trading range for PharmaCyte Biotech Inc share price?
PharmaCyte Biotech Inc has traded in the range of US$ 0.63 to US$ 1.51 during the past year
What is the PE ratio of PharmaCyte Biotech Inc?
The price to earnings ratio of PharmaCyte Biotech Inc is -0.69
What is the registered address of PharmaCyte Biotech Inc?
The registered address for PharmaCyte Biotech Inc is 3960 Howard Hughes Parkway, Las Vegas, Nevada, 89169
What is the PharmaCyte Biotech Inc website address?
The website address for PharmaCyte Biotech Inc is pharmacyte.com
Which industry sector does PharmaCyte Biotech Inc operate in?
PharmaCyte Biotech Inc operates in the Biotechnology & Life Sciences sector

PMCB 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

PMCB Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock